BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6839883)

  • 1. Distinction between 5-bromodeoxyuridine labeled and unlabeled mitotic cells by flow cytometry.
    Darzynkiewicz Z; Traganos F; Melamed MR
    Cytometry; 1983 Mar; 3(5):345-8. PubMed ID: 6839883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric detection of mitotic cells using the bromodeoxyuridine/DNA technique in combination with 90 degrees and forward scatter measurements.
    Nüsse M; Jülch M; Geido E; Bruno S; Di Vinci A; Giaretti W; Ruoss K
    Cytometry; 1989 May; 10(3):312-9. PubMed ID: 2496957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric estimation of cell cycle parameters using a monoclonal antibody to bromodeoxyuridine.
    Sasaki K; Murakami T; Ogino T; Takahashi M; Kawasaki S
    Cytometry; 1986 Jul; 7(4):391-5. PubMed ID: 3089742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA segments sensitive to single-strand-specific nucleases are present in chromatin of mitotic cells.
    Juan G; Pan W; Darzynkiewicz Z
    Exp Cell Res; 1996 Sep; 227(2):197-202. PubMed ID: 8831556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrimination of bromodeoxyuridine labelled and unlabelled mitotic cells in flow cytometric bromodeoxyuridine/DNA analysis.
    Jensen PO; Larsen JK; Christensen IJ; van Erp PE
    Cytometry; 1994 Feb; 15(2):154-61. PubMed ID: 8168402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can nocodazole, an inhibitor of microtubule formation, be used to synchronize mammalian cells? Accumulation of cells in mitosis studied by two parametric flow cytometry using acridine orange and by DNA distribution analysis.
    Nüsse M; Egner HJ
    Cell Tissue Kinet; 1984 Jan; 17(1):13-23. PubMed ID: 6692463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Denaturation and condensation of DNA in situ induced by acridine orange in relation to chromatin changes during growth and differentiation of Friend erythroleukemia cells.
    Darzynkiewicz Z; Traganos F; Kapuscinski J; Melamed MR
    Cytometry; 1985 May; 6(3):195-207. PubMed ID: 3858089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine.
    Hoshino T; Nagashima T; Murovic J; Levin EM; Levin VA; Rupp SM
    Cytometry; 1985 Nov; 6(6):627-32. PubMed ID: 2998714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermal denaturation of DNA for immunochemical staining of incorporated bromodeoxyuridine (BrdUrd): critical factors that affect the amount of fluorescence and the shape of BrdUrd/DNA histogram.
    Hoy CA; Seamer LC; Schimke RT
    Cytometry; 1989 Nov; 10(6):718-25. PubMed ID: 2582962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of mitotic melanoma cells from G2 cells and their isolation by use of 5-bromo-2'-deoxyuridine and propidium iodide.
    Trinkle LS; Swope VB; Abdel-Malek ZA; Nordlund JJ
    Cytometry; 1988 Sep; 9(5):432-5. PubMed ID: 3180943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromodeoxyuridine labeling and flow cytometric identification of replicating Saccharomyces cerevisiae cells: lengths of cell cycle phases and population variability at specific cell cycle positions.
    Dien BS; Srienc F
    Biotechnol Prog; 1991; 7(4):291-8. PubMed ID: 1367343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of denaturation with HCl on the immunological staining of bromodeoxyuridine incorporated into DNA.
    Sasaki K; Adachi S; Yamamoto T; Murakami T; Tanaka K; Takahashi M
    Cytometry; 1988 Jan; 9(1):93-6. PubMed ID: 2457476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quantitative method for evaluating bivariate flow cytometric data obtained using monoclonal antibodies to bromodeoxyuridine.
    White RA; Terry NH
    Cytometry; 1992; 13(5):490-5. PubMed ID: 1633728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of acridine orange to DNA in situ of cells from patients with acute leukemia.
    Walle AJ; Wong GY
    Cancer Res; 1989 Jul; 49(13):3692-5. PubMed ID: 2731183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of bromodeoxyuridine incorporation by alteration of the fluorescence emission from nucleic acid binding dyes using only an argon ion laser.
    Frey T
    Cytometry; 1994 Dec; 17(4):310-8. PubMed ID: 7875038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rapid and simple estimation of cell cycle parameters by continuous labeling with bromodeoxyuridine.
    Sasaki K; Murakami T; Takahashi M
    Cytometry; 1987 Sep; 8(5):526-8. PubMed ID: 3311660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry.
    Riccardi A; Danova M; Wilson G; Ucci G; Dörmer P; Mazzini G; Brugnatelli S; Girino M; McNally NJ; Ascari E
    Cancer Res; 1988 Nov; 48(21):6238-45. PubMed ID: 3167869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle analysis by combining the 5-bromodeoxyuridine/33258 Hoechst technique with DNA-specific ethidium bromide staining.
    Böhmer RM; Ellwart J
    Cytometry; 1981 Jul; 2(1):31-4. PubMed ID: 6168457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental parameters and a biological standard for acridine orange detection of drug-induced alterations in chromatin condensation.
    Block AL; Bauer KD; Williams TJ; Seidenfeld J
    Cytometry; 1987 Mar; 8(2):163-9. PubMed ID: 3107948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New cell cycle compartments identified by multiparameter flow cytometry.
    Darzynkiewicz Z; Traganos F; Melamed MR
    Cytometry; 1980 Sep; 1(2):98-108. PubMed ID: 6170495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.